How many Corcept Therapeutics shares are in issue?
Corcept Therapeutics has 103,081,000 shares in issue.
What is the market cap of Corcept Therapeutics?
The market capitalisation of Corcept Therapeutics is USD 1.88 B.
What is the 1 year trading range for Corcept Therapeutics share price?
Corcept Therapeutics has traded in the range of US$ 18.23 to US$ 18.23 during the past year.
What is the PE ratio of Corcept Therapeutics?
The price to earnings ratio of Corcept Therapeutics is 56.81.
What is the cash to sales ratio of Corcept Therapeutics?
The cash to sales ratio of Corcept Therapeutics is 12.50.
What is the reporting currency for Corcept Therapeutics?
Corcept Therapeutics reports financial results in USD.
What is the latest annual turnover for Corcept Therapeutics?
The latest annual turnover of Corcept Therapeutics is USD 482.38M.
What is the latest annual profit for Corcept Therapeutics?
The latest annual profit of Corcept Therapeutics is USD 106.14M.
What is the registered address of Corcept Therapeutics?
The registered address for Corcept Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801.
What is the Corcept Therapeutics website address?
The website address for Corcept Therapeutics is www.corcept.com.
Which industry sector does Corcept Therapeutics operate in?
Corcept Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
